Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHICL Infrastructure Regulatory News (HICL)

Share Price Information for HICL Infrastructure (HICL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 123.40
Bid: 118.40
Ask: 137.00
Change: 0.00 (0.00%)
Spread: 18.60 (15.709%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 123.40
HICL Live PriceLast checked at -
HICL Infrastructure is an Investment Trust

To deliver a long-term, stable income to shareholders from a diversified portfolio of infrastructure investments positioned at the lower end of the risk spectrum.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Preliminary Results of Placing

21 Mar 2013 12:00

RNS Number : 5442A
HICL Infrastructure Company Ld
21 March 2013
 



HICL Infrastructure Company Limited

21 March 2013

Not for publication, release of distribution in whole or in part in Australia, Canada, South Africa, Japan or the United States

 

Preliminary Results of Placing, Open Offer and Offer for Subscription of New Ordinary Shares

The Board of HICL Infrastructure Company Limited ("HICL") is pleased to announce that the Placing, Open Offer and Offer for Subscription of New Ordinary Shares (the 'Issue') has now closed and that, on the basis of applications received through the Open Offer and Offer for Subscription and of orders taken through the Placing, both the Issue's target size of 100 million Ordinary Shares (raising gross proceeds of £119.5 million) and its maximum potential size of 140 million Ordinary Shares (raising gross proceeds of £167.3 million) have been comfortably exceeded.

In accordance with the terms and conditions of the Issue, all applications made pursuant to Open Offer entitlements will be met in full. The Board is, in conjunction with its advisers, considering the basis upon which applications made pursuant to the Placing, the Offer for Subscription and (to the extent it is relevant) the Excess Application Facility should be scaled back given the high level of oversubscription in respect of the Issue.

The Board has consulted with the Investment Adviser, InfraRed Capital Partners Limited, on the Additional Investments which would allow the size of the Issue to be increased. As a result, the Board has decided that the overall size of the Issue will be set at its maximum of 140 million New Ordinary Shares.

A further announcement providing details of the basis upon which New Ordinary Shares will be allotted will be made on Friday 22 March 2013.

For further information, please contact: 

InfraRed Capital Partners Limited

Tony Roper

Keith Pickard

Robin Hubbard

David Foot

Erwan Fournis

 

+44 (0) 20 7484 1800

Canaccord Genuity Limited

David Yovichic

Lucy Lewis

Robbie Robertson

 

+44 (0) 20 7523 8000

Tulchan Communications

Ed Orlebar

 

+44 (0) 20 7353 4200

Dexion Capital (Guernsey) Limited

Gillian Newton

+44 (0) 1481 732814

Terms in this announcement shall have the same meaning as defined in the prospectus issued by HICL dated 26 February 2013.

Canaccord Genuity Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting for the Company and for no one else in connection with the Issue and will not be responsible to anyone other than the Company for providing the protections afforded to clients of Canaccord Genuity Limited or for affording advice in relation to the Issue, or any other matters referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJBMLTMBTTMJJ
Date   Source Headline
26th Sep 20172:30 pmRNSAdditional Listing
14th Sep 20175:31 pmRNSHolding(s) in Company
7th Sep 20177:00 amRNSCompletion of Acquisition
1st Sep 20172:11 pmRNSScrip Share Reference Price
26th Jul 20178:25 amRNSPreferred Bidder Announcement
24th Jul 20177:00 amRNSInterim Update Statement
21st Jul 20173:00 pmRNSScrip Dividend Circular
18th Jul 20173:33 pmRNSFirst Quarterly Interim Dividend
14th Jul 20172:50 pmRNSAcquisition
5th Jul 20173:40 pmRNSDirector/PDMR Shareholding
3rd Jul 20175:38 pmRNSTotal Voting Rights
22nd Jun 20172:00 pmRNSAdditional Listing
13th Jun 20178:44 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual General Meeting Circular
13th Jun 20177:00 amRNSAnnual Financial Report
5th Jun 20173:22 pmRNSResult of Equity Issue
2nd Jun 20171:24 pmRNSScrip Share Reference Price
24th May 20177:00 amRNSAnnual Results for the year ended 31 March 2017
24th May 20177:00 amRNSIssue of Equity
22nd May 20177:00 amRNSCompletion of Acquisition
18th May 201711:21 amRNSFourth Quarterly Interim Dividend
2nd May 20177:00 amRNSAcquisition of a new investment
2nd May 20177:00 amRNSIncrease in the Group's credit facility
10th Apr 20177:00 amRNSNotice of Annual Results
5th Apr 20174:00 pmRNSDirector/PDMR Shareholding
4th Apr 201710:28 amRNSHolding(s) in Company
3rd Apr 20178:00 amRNSIncremental Investment
31st Mar 20175:11 pmRNSTotal Voting Rights
29th Mar 20174:00 pmRNSDirector/PDMR Shareholding
24th Mar 20178:00 amRNSAdditional Listing and Total Voting Rights
22nd Mar 20174:00 pmRNSDirector/PDMR Shareholding
22nd Mar 201710:16 amRNSAdditional Listing
22nd Mar 20177:00 amRNSResult of Equity Issue
21st Mar 20179:28 amRNSTerms and Conditions of the Placing
20th Mar 201711:49 amRNSDirectorate Change
20th Mar 201711:36 amRNSResults of EGM
10th Mar 20178:00 amRNSCompletion of Acquisition
9th Mar 20172:37 pmRNSScrip Share Reference Price
23rd Feb 20175:41 pmRNSPublication of a Prospectus and Circular
23rd Feb 20175:00 pmRNSPublication of a Prospectus and Circular
22nd Feb 20174:45 pmRNSThird Quarterly Interim Dividend
2nd Feb 201711:44 amRNSInterim Update Statement February 2017
23rd Jan 20177:00 amRNSCompletion of Acquisition
12th Jan 20172:42 pmRNSIntention to issue new equity
5th Jan 20177:00 amRNSCompletion of Two Acquisitions
4th Jan 20174:00 pmRNSDirector/PDMR Shareholding
30th Dec 20164:00 pmRNSTotal Voting Rights
16th Dec 201612:32 pmRNSAdditional Listing
7th Dec 20163:45 pmRNSDirector/PDMR Shareholding
2nd Dec 201610:00 amRNSDirector Declaration - Additional Directorship

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.